| 1 | LLY | Eli Lilly and Company | 6.44% |
| 2 | MRK | Merck & Co., Inc. | 5.31% |
| 3 | AMGN | Amgen Inc. | 5.03% |
| 4 | JNJ | Johnson & Johnson | 5.00% |
| 5 | TVTX | Travere Therapeutics, Inc. | 4.81% |
| 6 | ABBV | AbbVie Inc. | 4.75% |
| 7 | GILD | Gilead Sciences, Inc. | 4.73% |
| 8 | PFE | Pfizer Inc. | 4.41% |
| 9 | ABT | Abbott Laboratories | 4.15% |
| 10 | UTHR | United Therapeutics Corporation | 3.66% |
| 11 | AVDL | Avadel Pharmaceuticals plc | 3.60% |
| 12 | JAZZ | Jazz Pharmaceuticals plc | 3.35% |
| 13 | TARS | Tarsus Pharmaceuticals, Inc. | 3.12% |
| 14 | REGN | Regeneron Pharmaceuticals, Inc. | 3.12% |
| 15 | BIIB | Biogen Inc. | 3.10% |
| 16 | AMRX | Amneal Pharmaceuticals, Inc. | 3.09% |
| 17 | LGND | Ligand Pharmaceuticals Incorporated | 2.97% |
| 18 | COLL | Collegium Pharmaceutical, Inc. | 2.75% |
| 19 | CORT | Corcept Therapeutics Incorporated | 2.69% |
| 20 | INVA | Innoviva, Inc. | 2.54% |
| 21 | SUPN | Supernus Pharmaceuticals, Inc. | 2.42% |
| 22 | BMY | Bristol-Myers Squibb Company | 2.42% |
| 23 | VTRS | Viatris Inc. | 2.36% |
| 24 | OCUL | Ocular Therapeutix, Inc. | 2.29% |
| 25 | HRMY | Harmony Biosciences Holdings, Inc. | 2.21% |
| View PJP holdings |
